Potential Therapy of Age-Related Macular Degeneration With Small Molecules
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2008 - June 30, 2010
Grant ID
M2008065
Goals
This project is looking for a small molecule that can penetrate the eye and diminish the eye inflammation that occurs in AMD. If successful, this small molecule can be administered at the earlier stages of AMD to halt progression to the later stages and eventual blindness. To identify such a molecule, we will screen a small molecule library and confirm its efficacy in a test tube before moving onto animal models.
Summary
Current treatments for AMD do not restore vision. In wet AMD, treatment is directed at the terminal stages, making it impossible to return vision to 20/20. For the dry type, the only treatment is a special vitamin preparation that is only effective in slowing the progression of AMD in some people. The researchers are investigating a small molecule that can penetrate the eye and diminish the eye inflammation that occurs in AMD. If successful, this small molecule could be administered in the earlier stages of AMD to halt disease progression and prevent blindness. They will identify such a molecule by screening a small molecule library and then will confirm its efficacy in a test tube before moving on to animal models.
Grants
Related Grants
Macular Degeneration Research
Exosomes and Autophagy: Suspicious Partners in Drusen Biogenesis and AMD
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Miguel Flores Bellver, PhD
Exosomes and Autophagy: Suspicious Partners in Drusen Biogenesis and AMD
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Miguel Flores Bellver, PhD
Macular Degeneration Research
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Maximilian Pfau, MD
Innovative Night Vision Tests for Age-Related Macular Degeneration
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Maximilian Pfau, MD
Macular Degeneration Research
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Heike Kroeger, PhD
The Generation of Cone Photoreceptor Outer Segments
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Heike Kroeger, PhD